10.2022

American Society of Clinical Oncology (ASCO) Annual Meeting (2022)

Subgroup Analysis of Non-Squamous EGFR Wild-Type (WT) 2nd/3rdLine NSCLC Patients from the Global Phase 3 Trial DUBLIN-3 (BPI-2358-103) with the Plinabulin/Docetaxel Combination vs. Docetaxel Alone